OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α

Molecular Cell

Volumn 17, Issue 4, 2005, Pages 503-512

  Baek, Jin Hyen ^a   Mahon, Patrick C ^a   Oh, Jane ^a   Kelly, Brian ^a   Krishnamachary, Balaji ^a   Pearson, Mia ^a   Chan, Denise A ^b   Giaccia, Amato J ^b   Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEASOME; PROTEIN DERIVATIVE; PROTEIN OS 9; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYDROXYLATION; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE;

METAZOA;

EID: 13944276440     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2005.01.011     Document Type: Article

References (41)

1. Berra E., Benizri E., Ginouves A., Volmat V., Roux D., Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22:2003;4082-4090
2. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 294:2001;1337-1340
3. Chan D.A., Sutphin P.D., Denko N.C., Giaccia A.J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α J. Biol. Chem. 277:2002;40112-40117
4. D'Angelo G., Duplan E., Boyer N., Vigne P., Frelin C. Hypoxia up-regulates prolyl hydroxylase activity. a feedback mechanism that limits HIF-1 responses during reoxygenation J. Biol. Chem. 278:2003;38183-38187
5. Dann C.E. III, Bruick R.K., Deisenhofer J. Structure of factor inhibiting hypoxia-inducible factor 1. an asparaginyl hydroxylase involved in the hypoxic response pathway Proc. Natl. Acad. Sci. USA. 99:2002;15351-15356
6. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:2001;43-54
7. Friedmann E., Salzburg Y., Weinberger A., Shaltiel S., Gerst J.E. YOS9, the putative yeast homologue of a gene amplified in osteosarcomas, is involved in the endoplasmic reticulum (ER)-Golgi transport of GPI-anchored proteins. J. Biol. Chem. 277:2002;35274-35281
8. Giaccia A., Siim B.G., Johnson R.S. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2:2003;803-811
9. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., et al. Hypoxia-inducible factor asparaginyl hydroxylase is identical to factor inhibiting HIF-1 (FIH-1) and is related to the cupin structural family. J. Biol. Chem. 277:2002;26351-26355
10. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278:2003;30772-30780
11. Hoffman C.S., Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene. 57:1987;267-272
12. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 95:1998;7987-7992
13. Huang J., Zhao Q., Mooney S.M., Lee F.S. Sequence determinants in hypoxia-inducible factor-1a for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J. Biol. Chem. 277:2002;39792-39800
14. 2 sensing Science. 292:2001;464-468
15. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., Yang H., Sorokina I., Conaway R.C., Conaway J.W., Kaelin W.G. Jr. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA. 99:2002;13459-13464
16. 2-regulated prolyl hydroxylation. Science. 292:2001;468-472
17. 2 tension. Am. J. Physiol. 271:1996;C1172-C1180
18. Kaelin W.G. Jr. How oxygen makes its presence felt. Genes Dev. 16:2002;1441-1445
19. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., Poellinger L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:1999;6519-6525
20. Kamura T., Sato S., Iwai K., Czyzyk-Krzeska M., Conaway R.C., Conaway J.W. Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. USA. 97:2000;10430-10435
21. Kimura Y., Nakazawa M., Tsuchiya N., Asakawa S., Yamada M. Genomic organization of the OS-9 gene amplified in human sarcomas. J. Biochem. (Tokyo). 122:1997;1190-1195
22. Kimura Y., Nakazawa M., Yamada M. Cloning and characterization of three isoforms of OS-9 cDNA and expression of the OS-9 gene in various human tumor cell lines. J. Biochem. (Tokyo). 123:1998;876-882
23. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16:2002;1466-1471. a
24. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain. a hypoxic switch Science. 295:2002;858-861. b
25. Litovchick L., Friedmann E., Shaltiel S. A selective interaction between OS-9 and the carboxyl-terminal tail of meprin β J. Biol. Chem. 277:2002;34413-34423
26. Mahon P.C., Hirota K., Semenza G.L. FIH-1. a novel protein that interacts with HIF-1alpha and vhl to mediate repression of HIF-1 transcriptional activity Genes Dev. 15:2001;2675-2686
27. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275
28. McNeill L.A., Hewitson K.A., Claridge T.D., Seibel J.F., Horsfall L.E., Schofield C.J. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyzes hydroxylation at the β-carbon of asparagine-803. Biochem. J. 367:2002;571-575
29. Metzen E., Berchner-Pfannschmidt U., Stengel P., Marxsen J.H., Stolze I., Klinger M., Huang W.Q., Wotzlaw C., Hellwig-Burgel T., Jelkmann W., et al. Intracellular localisation of human HIF-1α hydroxylases. implications for oxygen sensing J. Cell Sci. 116:2003;1319-1326
30. Nakayama T., Yaoi T., Kuwajima G., Yoshie O., Sakata T. Ca2(+)-dependent interaction of N-copine, a member of the two C2 domain protein family, with OS-9, the product of a gene frequently amplified in osteosarcoma. FEBS Lett. 18:1999;77-80
31. Nakayama K., Frew I.J., Hagensen M., Skals M., Habelhah H., Bhoumik A., Kadoya T., Erdjument-Bromage H., Tempst P., Frappell P.B., et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF-1α abundance, and modulates physiological responses to hypoxia. Cell. 117:2004;941-952
32. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia. role of the HIF system Nat. Med. 9:2003;677-684
33. Salceda S., Caro J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272:1997;22642-22647
34. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3:2003;721-732
35. Semenza G.L., Jiang B.-H., Leung S.W., Passantino R., Concordet J.P., Maire P., Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271:1996;32529-32537
36. Su Y.A., Hutter C.M., Trent J.M., Meltzer P.S. Complete sequence analysis of a gene (OS-9) ubiquitously expressed in human tissues and amplified in sarcomas. Mol. Carcinog. 15:1996;270-275
37. Vigneron N., Ooms A., Morel S., Degiovanni G., Van den Eynde B.J. Identification of a new peptide recognized by cytolytic T lymphocytes on a human melanoma. Cancer Immun. 2:2002;9
38. 2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514
39. Yu F., White S.B., Zhao Q., Lee F.S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA. 98:2001;9630-9635
40. Zagzag D., Zhong H., Scalzitti J.M., Laughner E., Simons J.W., Semenza G.L. Expression of hypoxia-inducible factor 1α in human brain tumors. association with angiogenesis, invasion, and progression Cancer. 88:2000;2606-2618
41. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835